Darin Sutton, MD
Plastic Surgery within the Head & Neck · Conway, SCNPI 1285606350
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Merz North America, Inc. at 44.2% of the total. Reporting peaked in 2022 at $478 and has fallen 55.4% since, to $213 in 2025.
Across 33 payments — averaging $32.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$478
- Merck$116
- Sanofi$111
- Optinose US, Inc.$77
- GSK$75
- Medtronic$40
- plus $185 from 7 others
What the payments were for
- Food & beverage$1,03095%
- Education$515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 5 | $478 |
| Merck | 5 | $116 |
| Sanofi | 3 | $111 |
| Optinose US, Inc. | 5 | $77 |
| GSK | 4 | $75 |
| Medtronic(2 entities) | 2 | $40 |
| Polynovo North America LLC | 1 | $33 |
| Stryker | 1 | $32 |
| Olympus America Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Kerecis Limited | 1 | $26 |
| Acclarent, Inc | 1 | $21 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$259
How this compares
Too few plastic surgery within the head & neck providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 340 | $5,135 |
| Fluticasone Propionate | 382 | $4,747 |
| Ipratropium Bromide | 117 | $2,716 |
| Mometasone Furoate | 39 | $2,711 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $1,842 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 28 | $1,519 |
| Pantoprazole Sodium | 104 | $1,282 |
| Cefdinir | 48 | $934 |
| Levothyroxine Sodium | 71 | $746 |
| Prednisone | 107 | $717 |
| Famotidine | 65 | $691 |
| Montelukast Sodium | 60 | $626 |
| Esomeprazole Magnesium | 30 | $622 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $360 |
| Azelastine Hcl | 19 | $335 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in Conway
- Alicia SandersonConway$918
- Trinitia CannonCharleston$6K
- Blake HollowoaCharleston$4K
- Daniel RosnerMyrtle Beach$3K
- David LobbGreenville$2K
- Brian AndersonSpartanburg$2K
- Richard OsmanMyrtle Beach$1K
- William ThomasGreenville$809
- Robert BrownGreenville$636
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.